Lv11
80 积分 2025-11-02 加入
CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool forin vitropreclinical studies with primary B-cell malignancies
7小时前
待确认
Cbx2 as a Therapeutic Target in Colorectal Cancer: Insights into the Altered Chromatin Accessibility Via Runx1-Cbx2-Map4k1 Axis
5个月前
已完结
Isolation and Cryopreservation of Mononuclear Cells from Peripheral Blood and Bone Marrow of Blood Cancer Patients
6个月前
已完结
Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
6个月前
已关闭
The conundrum of drug development in higher-risk MDS: Lessons learned from recently failed phase 3 clinical trials
7个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors
7个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
11个月前
已完结
皖公网安备34019202002308
